Nutriband Inc. exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. The company is experiencing a collapse in top-line growth with revenue declining by 46.4% YoY, coupled with an unsustainable operating margin of -1121.30%. While the balance sheet shows high short-term liquidity (Current Ratio 7.53) and low leverage, these are insufficient to offset the massive operational losses and negative ROE of -136.08%. The technical trend is entirely bearish, and the lack of analyst coverage suggests a lack of institutional confidence.